| PrEP Stigma: Implicit and Explicit Drivers of Disparity |
35 |
| The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions |
26 |
| Sex Differences in HIV Infection |
22 |
| Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring |
21 |
| Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C |
19 |
| HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration |
17 |
| HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy |
15 |
| Implementation Strategies to Increase PrEP Uptake in the South |
15 |
| Quarter Century of Anti-HIV CAR T Cells |
11 |
| Genetic Cluster Analysis for HIV Prevention |
10 |
| Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART? |
9 |
| A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP) |
9 |
| HIV Prevention Interventions for Adolescents |
9 |
| A Review of Differentiated Service Delivery for HIV Treatment: Effectiveness, Mechanisms, Targeting, and Scale |
9 |
| Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework |
8 |
| HIV Eradication Strategies: Implications for the Central Nervous System |
8 |
| History of the HIV Epidemic in China |
7 |
| Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment |
7 |
| HIV Persistence in Adipose Tissue Reservoirs |
7 |
| Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
7 |
| The Role of Integrin alpha(4)beta(7) in HIV Pathogenesis and Treatment |
7 |
| Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy |
6 |
| Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era |
6 |
| How to Evolve the Response to the Global HIV Epidemic With New Metrics and Targets Based on Pre-Treatment CD4 Counts |
6 |
| Implementation of eHealth Interventions Across the HIV Care Cascade: a Review of Recent Research |
6 |
| Health Behavior Theory to Enhance eHealth Intervention Research in HIV: Rationale and Review |
6 |
| Federal Response to the Opioid Crisis |
6 |
| Evolving HIV Epidemiology in Mainland China: 2009-2018 |
5 |
| eHealth to Enhance Treatment Adherence Among Youth Living with HIV |
5 |
| Medications for Treatment of Opioid Use Disorder among Persons Living with HIV |
5 |
| The Association Between Marijuana Use and HIV Continuum of Care Outcomes: a Systematic Review |
5 |
| Confronting Rising STIs in the Era of PrEP and Treatment as Prevention |
5 |
| Crowdsourcing to Improve HIV and Sexual Health Outcomes: a Scoping Review |
5 |
| Design Considerations for Implementing eHealth Behavioral Interventions for HIV Prevention in Evolving Sociotechnical Landscapes |
5 |
| Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned |
5 |
| Serious Non-AIDS Conditions in HIV: Benefit of Early ART |
4 |
| Solid Organ Transplantation in HIV-Infected Recipients: History, Progress, and Frontiers |
4 |
| Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy |
4 |
| Interventions to improve the HIV continuum of care in China |
4 |
| Inflammation Strikes Again: Frailty and HIV |
4 |
| The Dual Role of Neutrophils in HIV Infection |
4 |
| Impact of Myeloid Reservoirs in HIV Cure Trials |
4 |
| Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations |
4 |
| Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection |
4 |
| Substance Use and HIV Among Justice-Involved Youth: Intersecting Risks |
4 |
| The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV |
3 |
| New Strategies of ARV: the Road to Simplification |
3 |
| Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis |
3 |
| HIV and Solid Organ Transplantation: Where Are we Now |
3 |
| eHealth and Prevention of Mother-to-Child Transmission of HIV |
3 |
